ExploreWatchlistsPricing
  1. JP-listed companies
  2. SATO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Earnings per share

SATO PHARMACEUTICAL CO.,LTD. (E00954)

Market cap
P/E ratio
Sato Pharmaceutical develops and sells over-the-counter medicines, prescription drugs, and health products to consumers and medical institutions globally.
SummaryFinancialsDividendsHistorySegmentsWorkforce
Period EndEarnings per share (JPY)YoY (%)
Jul 31, 2023399.2+164.64%
Jul 31, 2022150.8+36.10%
Jul 31, 2021110.8-71.00%
Jul 31, 2020382.1-5.65%
Jul 31, 2019405+136.02%
Jul 31, 2018171.6-340.47%
Jul 31, 2017-71.4+35.49%
Jul 31, 2016-52.7-122.86%
Jul 31, 2015230.4-37.55%
Jul 31, 2014369-24.31%
Jul 31, 2013487.5+71.85%
Jul 31, 2012283.7-0.89%
Jul 31, 2011286.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat